BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $453,828 | +229.8% | 64,100 | +288.5% | 0.03% | +200.0% |
| Q1 2023 | $137,610 | -80.8% | 16,500 | -66.9% | 0.01% | -80.8% |
| Q3 2021 | $715,000 | +2066.7% | 49,800 | +2271.4% | 0.05% | +1633.3% |
| Q2 2021 | $33,000 | -79.5% | 2,100 | -86.8% | 0.00% | -80.0% |
| Q1 2021 | $161,000 | +403.1% | 15,900 | +69.1% | 0.02% | +275.0% |
| Q3 2020 | $32,000 | -68.0% | 9,400 | +39.1% | 0.00% | -77.8% |
| Q2 2015 | $100,000 | +85.2% | 6,759 | +22.3% | 0.02% | +157.1% |
| Q3 2014 | $54,000 | +440.0% | 5,527 | +452.7% | 0.01% | +250.0% |
| Q1 2014 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |